LAMP
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 May 2023)
What this means for you
This application is over — abandoned 29 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88787581
- Mark type
- Stylized text
- Filed
- 06 Feb 2020
- Published for opposition
- 03 Nov 2020
- Abandoned
- 29 May 2023
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
- Class 042 — Scientific and technological services: scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
- Class 044 — Medical, beauty and agricultural services: providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Owner
- CytoDyn Inc., Vancouver, WA, US
- CytoDyn Inc., Vancouver, WA, US
Prosecution history
- 30 May 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 May 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2022 — SOU EXTENSION 3 GRANTED
- 27 Oct 2022 — SOU EXTENSION 3 FILED
- 27 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2022 — SOU EXTENSION 2 GRANTED
- 27 Apr 2022 — SOU EXTENSION 2 FILED
- 27 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 27 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2021 — SOU EXTENSION 1 GRANTED
- 25 Oct 2021 — SOU EXTENSION 1 FILED
- 25 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 27 Apr 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT